Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer

NCT04346914 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Extensive Stage Small Cell Lung Cancer

Interventions

BIOLOGICAL: recombinant anti-PD-L1 monoclonal antibody injection combined with carboplatin and etoposide

Sponsor

Lee's Pharmaceutical Limited